Aushon Biosystems Inc.
Funding rounds
5 counted as startup funding. Open the number of investors for the round's details.
| Month | Raised | Raise | Size | Investors | Sold | Filing |
|---|---|---|---|---|---|---|
| Jul 2016 | $7 M | No. 5 | $2 to $10 million | equity | SEC | |
| Nov 2014 | $8 M | No. 4 | $2 to $10 million | equity | SEC | |
| Sep 2012 | $6 M | No. 3 | $2 to $10 million | equity | SEC | |
| Jul 2010 | $2 M | No. 2 | Under $2 million | equity | SEC | |
| Mar 2009 | $5 M | No. 1 | $2 to $10 million | equity | SEC |
Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.
How it makes money#
What its filings and its own website say, sentence by sentence, each with its source.
Aushon Biosystems Inc. chose not to state its revenue in its newest notice of a funding round (Nov 2016).
SEC Form D · Nov 2016
The industry group it chose in its notices: Other.
SEC Form D · Nov 2016
That is all the official record says: Aushon Biosystems Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.
Products and services#
No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).
Investors#
No investor of Aushon Biosystems Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.
Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 5 rounds above had up to 17 investors.
Executives and directors
As the company named them in its notices. Directors of a funded startup are often partners of its investors.
| Name | Role | Named in |
|---|---|---|
| Peter Honkanen | Executive officer | Nov 2016 |
| Susan P. Keefe | Executive officer | Nov 2016 |
| Susan Vogt | Executive officer | Nov 2016 |
| John S. Ledoux | Executive officer | Sep 2012 |
| Martin Verhoef | Executive officer | Sep 2012 |
| Joseph S. Blanchard | Executive officer | Dec 2011 |
| Lisa S. Mastrangelo | Executive officer | Dec 2011 |
| Kenneth Titlebaum | Executive officer | Mar 2009 |
| Bruns P. Grayson | Director | Nov 2016 |
| Carmichael S. Roberts | Director | Nov 2016 |
| James Iuliano | Director | Nov 2016 |
| Peter Honkanen | Director | Nov 2016 |
| Susan Vogt | Director | Nov 2016 |
| Thomas P. Mac Mahon | Director | Nov 2016 |
| James A Iuliano | Director | Sep 2012 |
| Jean-Paul S. Mangeolle | Director | Sep 2012 |
| Martin Verhoef | Director | Sep 2012 |
| Richard A D'Amore | Director | Sep 2012 |
| John Austin | Director | Dec 2011 |
| James Little | Director | Mar 2009 |
| Kenneth Titlebaum | Director | Mar 2009 |